Statin Use Shows Increased Overall Survival in Patients Diagnosed With Pancreatic Cancer: A Meta-Analysis

Pancreas. 2019 Apr;48(4):e22-e23. doi: 10.1097/MPA.0000000000001276.

Authors

Danlu Wang¹, Eduardo A Rodriguez, Jamie S Barkin, Elie M Donath, Ali S Pakravan

Affiliation

¹ Department of Medicine University of Miami/JFK Medical Center Palm Beach Regional GME Consortium Atlantis, FL danlu51050@gmail.com Department of Medicine Division of Gastroenterology University of Miami Leonard Miller School of Medicine University of Miami Hospital and Clinics Miami, FL Department of Medicine University of Miami/JFK Medical Center Palm Beach Regional GME Consortium Atlantis, FL.

PMID: 30973465
DOI: 10.1097/MPA.0000000000001276

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

Adenocarcinoma / diagnosis
Adenocarcinoma / drug therapy*
Aged
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Male
Middle Aged
Outcome Assessment, Health Care / methods
Outcome Assessment, Health Care / statistics & numerical data
Pancreatic Neoplasms / diagnosis
Pancreatic Neoplasms / drug therapy*
Retrospective Studies
Survival Analysis

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors